Atrial fibrillation (AF) and tricuspid regurgitation (TR) may induce congestive heart failure (CHD). Using electrocardiography and echocardiography, we examined the clinical characteristics and haemodynamic findings in 100 patients with AF + TR + CHF, AF + TR, AF or TR. The fractional shortening in all groups with AF was significantly decreased compared with the TR group. The ejection fraction in patients with AF + TR + CHF was significantly lower than in the TR group. Twenty-four of the 72 patients with AF and TR (with or without CHF) were treated, and 13 were monitored for heart rate and severity of TR. Eight months after start of treatment the heart rate and typical symptoms and signs of heart failure had improved significantly in nine patients, but the severity of TR did not change. TR worsened in the remaining four patients but they did not develop CHF. Our results suggest that increased heart rate due to the combination of AF and TR could be responsible for CHF.
Introduction
The prevalence of congestive heart failure (CHF) is increasing in all patient populations according to hospital discharge listings. 1 This is a result of the increasing frequency of elderly patients with CHF. 2 Age-related cardiovascular changes, with the exception of coronary artery disease and systemic hypertension, induce poor cardiac function and lead to the development of symptomatic CHF. 3 The mechanism of agerelated changes in cardiac function and morphology, however, is not well known in terms of CHF development.
Echocardiography is a useful technique for assessing cardiac function. For example, twodimensional echocardiography can provide information about left ventricular wall motion, and pulsed Doppler echocardiography can determine the severity of valvular regurgitation. 4 Colour Doppler imaging can also identify valvular regurgitation in the absence of typical signs of valvular diseases in the elderly. 5 The frequency of tricuspid regurgitation (TR) has recently been shown to increase with age. 6 Atrial fibrillation (AF) can occasionally cause CHF. 7 -9 AF is responsible for haemodynamic deterioration through both rapid ventricular responses and loss of the atrial contribution to ventricular filling. 10 To the best of our knowledge, however, the combination of AF and TR leading to CHF has not yet been reported. We hypothesized that the presence of TR alone did not lead to CHF. We therefore wanted to determine the clinical characteristics and haemodynamic findings in patients with evidence of AF and TR, to clarify the association between CHF, AF and TR.
Patients and methods

PATIENT POPULATION
Patients showing cardiovascular symptoms, such as chest discomfort, palpitation and dyspnoea who were evaluated at Gunma University Hospital were examined for the presence of CHF. Patients with AF or TR, based on electrocardiograpic and echocardiographic findings, were enrolled in this study. Informed consent for participation was obtained from each individual. Ethical approval was not needed.
Heart failure was defined as the presence of typical symptoms and signs of heart failure, including New York Heart Association (NYHA) functional class II, III or IV, and clinical improvement in response to diuretics. 11 The patients enrolled in our study were divided into the following four groups: AF + TR + CHF (patients with AF, TR and CHF); AF + TR; AF (AF alone); and TR (TR alone). Patients with AF and TR, with or without CHF, were treated with appropriate agents (digitalis and diuretics). These patients were monitored every 2 months, for 8 months, for changes in clinical characteristics and haemodynamic findings, using electrocardiograpic and echocardiographic examinations where possible.
ELECTROCARDIOGRAPHIC EXAMINATION
Electrocardiography (ECG) was performed at the Medical Laboratory Center of Gunma University Hospital. All standard ECG leads were simultaneously recorded at a sampling rate of 500 Hz. Any ECG records of poor technical quality were excluded from the study analysis. We used a program developed by Marquette Electronics (12SL ECG analysis program; Milwaukee, WI, USA) to evaluate the ECG data. The clinical diagnosis of AF was based on the American College of Physicians/American College of Cardiology/American Heart Association Task Force guidelines. 12 
ECHOCARDIOGRAPHIC EXAMINATION
The clinical diagnosis of TR was based on echocardiography findings. The severity of TR was assessed semi-quantitatively using pulsed Doppler techniques performed in both the parasternal and apical longitudinal views. The fractional shortening (FS) and ejection fraction (EF) were measured by a single blinded observer at baseline and follow-up time-points.
STATISTICAL ANALYSIS
Data are expressed as the mean ± standard deviation. The association between clinical characteristics and haemodynamic findings was analysed by one-way analysis of variance. A P-value < 0.05 was considered to be statistically significant.
Results
One hundred patients with AF and/or TR were enrolled in the study. The mean age was 64 years (range: 38 -88 years). The AF + TR + CHF group comprised 13 patients, whereas the AF + TR group contained 59 patients. Fifteen patients had TR alone and 13 had only AF.
The clinical characteristics and haemodynamic data for all patients are summarized in Table 1 . The heart rate in the group with AF + TR + CHF was significantly higher than in the TR group (Table 1 ; P < 0.05). Heart rate in patients with AF + TR and AF, however, was not significantly different from that in patients with TR. Stroke volume and cardiac output were not significantly different among the four groups. Fractional shortening in patients with AF + TR + CHF, AF + TR and AF was significantly lower than in the group with TR (26 ± 9%, 30 ± 8%, 29 ± 7% versus 37 ± 8%, respectively; P < 0.05). The EF in patients with AF + TR + CHF was significantly lower than in those with TR ( Fig. 1 ; P < 0.05).
Twenty-four of the 72 patients with AF + TR + CHF or AF + TR were treated with agents including digitalis and diuretics. Thirteen of these patients were monitored for changes in NYHA functional class, heart rate, EF and severity of TR for 8 months after initiation of treatment. The NYHA class, heart rate and EF for nine of the patients improved significantly ( Fig. 2 ; P < 0.05), but the severity of their TR did not change (Fig. 2) . In the remaining four patients, TR worsened but they did not develop CHF.
Discussion
Atrial fibrillation is a common disease in elderly patients. 10, 11 In a cohort study of elderly individuals, the frequency of AF increased with age. AF was also associated with an increased risk of heart failure, valvular heart diseases, stroke and hypertension, and is related to a greater rate of sudden death. The Vasodilator Heart Failure Trial study, however, found that AF did not increase the mortality rate. 10 Furthermore, AF does not adversely affect mortality, exercise capacity or morbidity from embolic events. 13 The cause of TR is thought to be enlargement of the tricuspid valve annulus, due to primary and secondary pulmonary hypertension and structural abnormalities of the tricuspid valve complex (such as tricuspid valve prolapse or rupture).
14 AF may result from annular dilation of the mitral and tricuspid valves. Annular dilation and valvular regurgitation are significantly greater for the tricuspid than the mitral valve. 15 In this study we did not observe prolapse of the tricuspid valve caused by pulmonary hypertension.
A post-mortem case demonstrated that annular dilation of the tricuspid valve without associated structural abnormalities of the valve complex could cause TR in an elderly patient. 16 There are, however, no precise clinical data regarding this phenomenon.
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It is difficult to establish a clinical diagnosis of CHF in elderly patients because of the absence of typical symptoms or physical findings of heart failure. These symptoms and signs could be underestimated in the presence of complicated disorders or changes associated with ageing. 17 Pulmonary hypertension and severe mitral or aortic regurgitation can induce severe TR. 18 Using colour Doppler echocardiography, moderately severe TR is frequently observed in healthy elderly individuals without valvular overload from either ventricle. Our data suggest that TR alone may not lead to CHF.
Therapeutic interventions should be used to control heart rate, resulting in improvement in NYHA functional class and EF. The use of optimal therapy (digoxin, β-blockers or calcium channel blockers) is usually recommended to regulate tachycardia caused by AF. Recent studies have proven the beneficial effects of amlodipine (a calcium channel blocker) 19 and carvedilol (a β-blocker) 17 in elderly patients with heart failure. In summary, 13 patients with AF and TR were monitored for changes in heart rate and the severity of TR for 8 months after starting treatment. The increased heart rate in nine patients significantly improved together with improvement in typical symptoms and signs of heart failure. The severity of TR, however, did not change. Four patients showed worsening of their TR, but did not develop CHF. Our results, therefore, suggest that increased heart rate, due to the combination of AF and TR, rather than the severity of TR could contribute to the development of CHF. 
